Skip to main content
Top
Published in: Intensive Care Medicine 4/2019

01-04-2019 | Original

Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial

Authors: Christophe Guitton, Stephan Ehrmann, Christelle Volteau, Gwenhael Colin, Adel Maamar, Vanessa Jean-Michel, Pierre-Joachim Mahe, Mickael Landais, Noelle Brule, Cedric Bretonnière, Olivier Zambon, Mickael Vourc’h

Published in: Intensive Care Medicine | Issue 4/2019

Login to get access

Abstract

Purpose

Preoxygenation with high-flow therapy by nasal cannulae (HFNC) is now widespread in the intensive care unit (ICU). However, no large randomized study has assessed its relevance in non-severely hypoxemic patients. In a randomized controlled trial (PROTRACH study), we aimed to evaluate preoxygenation with HFNC vs. standard bag-valve mask oxygenation (SMO) in non-severely hypoxemic patients during rapid sequence intubation (RSI) in the ICU.

Methods

Randomized controlled trial including non-severely hypoxemic patients requiring intubation in the ICU. Patients received preoxygenation by HFNC or SMO during RSI. HFNC was maintained throughout the intubation procedure whereas SMO was removed to perform laryngoscopy. The primary outcome was the lowest pulse oximetry (SpO2) throughout the intubation procedure. Secondary outcomes included drop in SpO2, adverse events related to intubation, and outcome in the ICU.

Results

A total of 192 patients were randomized. In the intent-to-treat analysis, 184 patients (HFNC n = 95; SMO n = 89), the median [IQR] lowest SpO2 was 100% [97; 100] for HFNC and 99% [95; 100] for the SMO group (P = 0.30). Mild desaturation below 95% was more frequent with SMO (23%) than with HFNC (12%) (RR 0.51, 95% CI 0.26–0.99, P = 0.045). There were fewer adverse events in the HFNC group (6%) than in the SMO group (19%) (RR 0.31, 95% CI 0.13–0.76, P = 0.007), including fewer severe adverse events, respectively 6 (6%) and 14 (16%) with HFNC and SMO (RR 0.38, 95% CI 0.15–0.95, P = 0.03).

Conclusions

Compared with SMO, preoxygenation with HFNC in the ICU did not improve the lowest SpO2 during intubation in the non-severely hypoxemic patients but led to a reduction in intubation-related adverse events.

Trial registration

Clinical trial Submission: 7 March 2016. Registry name: Benefits of high-flow nasal cannulae oxygen for preoxygenation during intubation in non-severely hypoxemic patients: the PROTRACH study. Clinicaltrials.gov identifier: NCT02700321. Eudra CT: 2015-A00145-44. CPP: 15/13-975 (Comité de protection des personnes de Rennes). URL registry: https://​clinicaltrials.​gov/​ct2/​show/​record/​NCT02700321.
Appendix
Available only for authorised users
Literature
8.
go back to reference Benumof JL (1999) Preoxygenation: best method for both efficacy and efficiency. Anesthesiology 91:603–605CrossRefPubMed Benumof JL (1999) Preoxygenation: best method for both efficacy and efficiency. Anesthesiology 91:603–605CrossRefPubMed
11.
go back to reference Roca O, Riera J, Torres F, Masclans JR (2010) High-flow oxygen therapy in acute respiratory failure. Respir Care 55:408–413PubMed Roca O, Riera J, Torres F, Masclans JR (2010) High-flow oxygen therapy in acute respiratory failure. Respir Care 55:408–413PubMed
13.
go back to reference Jaber S, Monnin M, Girard M et al (2016) Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial. Intensive Care Med 42:1877–1887. https://doi.org/10.1007/s00134-016-4588-9 CrossRefPubMed Jaber S, Monnin M, Girard M et al (2016) Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial. Intensive Care Med 42:1877–1887. https://​doi.​org/​10.​1007/​s00134-016-4588-9 CrossRefPubMed
17.
go back to reference Mort TC (2005) Preoxygenation in critically ill patients requiring emergency tracheal intubation. Crit Care Med 33:2672–2675CrossRefPubMed Mort TC (2005) Preoxygenation in critically ill patients requiring emergency tracheal intubation. Crit Care Med 33:2672–2675CrossRefPubMed
20.
go back to reference American Society of Anesthesiologists Task Force on Management of the Difficult Airway (2003) Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 98:1269–1277CrossRef American Society of Anesthesiologists Task Force on Management of the Difficult Airway (2003) Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 98:1269–1277CrossRef
21.
go back to reference Adnet F, Borron SW, Racine SX et al (1997) The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology 87:1290–1297CrossRefPubMed Adnet F, Borron SW, Racine SX et al (1997) The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology 87:1290–1297CrossRefPubMed
Metadata
Title
Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial
Authors
Christophe Guitton
Stephan Ehrmann
Christelle Volteau
Gwenhael Colin
Adel Maamar
Vanessa Jean-Michel
Pierre-Joachim Mahe
Mickael Landais
Noelle Brule
Cedric Bretonnière
Olivier Zambon
Mickael Vourc’h
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 4/2019
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-019-05529-w

Other articles of this Issue 4/2019

Intensive Care Medicine 4/2019 Go to the issue